Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2000;31:1162-1172

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krugers, H. J.
Right arrow Articles by Holsboer, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krugers, H. J.
Right arrow Articles by Holsboer, F.
Related Collections
Right arrow Neuroprotectors
Right arrow Animal models of human disease
Right arrow Acute Stroke Syndromes

(Stroke. 2000;31:1162.)
© 2000 American Heart Association, Inc.


Original Contributions

The Corticosterone Synthesis Inhibitor Metyrapone Prevents Hypoxia/Ischemia-Induced Loss of Synaptic Function in the Rat Hippocampus

Harm J. Krugers, PhD; Suharti Maslam, MSc; Jakob Korf, PhD Marian Joëls, PhD

From the Institute for Neurobiology (H.J.K., S.M., M.J.), Graduate School for Neurosciences, University of Amsterdam, and the Department of Biological Psychiatry (H.J.K., J.K.), Graduate School for Behavioral and Cognitive Neurosciences, University of Groningen, the Netherlands.

Correspondence to Harm J. Krugers, PhD, Institute for Neurobiology, Kruislaan 320, 1098 SM Amsterdam, The Netherlands. E-mail krugers{at}bio.uva.nl

Background and Purpose—Ischemia is accompanied by abundant corticosterone secretion, which could potentially exacerbate brain damage via activation of glucocorticoid receptors. We addressed whether manipulating steroid levels during ischemia affects hippocampal synaptic function along with neuronal structure. Moreover, we established whether pretreatment with the glucocorticoid receptor antagonist RU38486 is as effective in preventing deleterious effects after ischemia as is the steroid synthesis inhibitor metyrapone.

Methods—Rats underwent 20 minutes of unilateral hypoxia/ischemia (HI). Convulsions were monitored after HI, and 24 hours later, field potentials were recorded in vitro in the hippocampal CA1 area in response to stimulation of the Schaffer collateral/commissural fibers. Morphological alterations were determined in brain slices from the same animals. Data were correlated with steroid treatment before HI.

Results—Metyrapone suppressed plasma corticosteroid levels during HI, whereas corticosterone treatment significantly elevated plasma steroid levels. These treatments affected the incidence of visible seizures after HI: corticosterone treatment resulted in the highest incidence, whereas metyrapone attenuated the occurrence of seizures. Moreover, the HI-induced impairment in synaptic transmission in the CA1 area in vitro was exacerbated by concomitant corticosteroid treatment and alleviated by pretreatment with metyrapone. In parallel, degenerative changes in the hippocampus after HI were most pronounced after corticosterone treatment, whereas metyrapone reduced these alterations. RU38486 was effective only in reducing the incidence of seizures shortly after ischemia.

Conclusions—We tentatively conclude that synaptic function along with cellular integrity is preserved after HI by preventing the ischemia-evoked rise in corticosteroid levels rather than blocking the glucocorticoid receptor.

Editorial Comment

Florian Holsboer, MD, PhD, Guest Editor

Max Planck Institute of Psychiatry, München, Germany




This article has been cited by other articles:


Home page
EndocrinologyHome page
N. Oyamada, M. Sone, K. Miyashita, K. Park, D. Taura, M. Inuzuka, T. Sonoyama, H. Tsujimoto, Y. Fukunaga, N. Tamura, et al.
The Role of Mineralocorticoid Receptor Expression in Brain Remodeling after Cerebral Ischemia
Endocrinology, August 1, 2008; 149(8): 3764 - 3777.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. D. Munhoz, L. B. Lepsch, E. M. Kawamoto, M. B. Malta, L. d. S. Lima, M. C. Werneck Avellar, R. M. Sapolsky, and C. Scavone
Chronic unpredictable stress exacerbates lipopolysaccharide-induced activation of nuclear factor-kappaB in the frontal cortex and hippocampus via glucocorticoid secretion.
J. Neurosci., April 5, 2006; 26(14): 3813 - 3820.
[Abstract] [Full Text] [PDF]